JPH0354089B2 - - Google Patents

Info

Publication number
JPH0354089B2
JPH0354089B2 JP57083370A JP8337082A JPH0354089B2 JP H0354089 B2 JPH0354089 B2 JP H0354089B2 JP 57083370 A JP57083370 A JP 57083370A JP 8337082 A JP8337082 A JP 8337082A JP H0354089 B2 JPH0354089 B2 JP H0354089B2
Authority
JP
Japan
Prior art keywords
withdrawal
treatment
symptoms
drug according
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57083370A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5823630A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5823630A publication Critical patent/JPS5823630A/ja
Publication of JPH0354089B2 publication Critical patent/JPH0354089B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP57083370A 1981-05-21 1982-05-19 薬剤禁断症状の処置剤 Granted JPS5823630A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH330681 1981-05-21
CH3306/81-7 1981-05-21

Publications (2)

Publication Number Publication Date
JPS5823630A JPS5823630A (ja) 1983-02-12
JPH0354089B2 true JPH0354089B2 (en, 2012) 1991-08-19

Family

ID=4253131

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57083370A Granted JPS5823630A (ja) 1981-05-21 1982-05-19 薬剤禁断症状の処置剤

Country Status (11)

Country Link
US (2) US4444758A (en, 2012)
EP (1) EP0065747B1 (en, 2012)
JP (1) JPS5823630A (en, 2012)
AU (1) AU552547B2 (en, 2012)
CA (1) CA1188989A (en, 2012)
DE (1) DE3218761A1 (en, 2012)
IE (1) IE53395B1 (en, 2012)
IL (1) IL65782A (en, 2012)
IT (1) IT1152116B (en, 2012)
PH (1) PH17981A (en, 2012)
ZA (1) ZA823369B (en, 2012)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486599A (en) * 1989-03-29 1996-01-23 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
US5486362A (en) * 1991-05-07 1996-01-23 Dynagen, Inc. Controlled, sustained release delivery system for treating drug dependency
US5403595A (en) * 1991-05-07 1995-04-04 Dynagen, Inc. Controlled, sustained release delivery system for smoking cessation
US5780051A (en) * 1992-04-02 1998-07-14 Dynagen, Inc. Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
ES2395268T3 (es) * 1997-09-04 2013-02-11 Demerx, Inc. Noribogaína para el tratamiento del dolor y la drogadicción
CA2360124A1 (en) * 1999-02-05 2000-08-10 The Victoria University Of Manchester Regulation of anaesthesia
DE10014007A1 (de) * 2000-03-22 2001-10-11 Strathmann Ag & Co Neue Darreichungsformen für DSIP
RU2005128993A (ru) * 2005-09-08 2007-03-20 Общество С Ограниченной Ответственностью Исследовательский Центр "Комкон" (Ru) Средство для коррекции стресс-индуцируемых нейромедиаторных, нейроэндокринных и метаболических нарушений, а также способ профилактики и лечения сопутствующих им паталогических состояний
EP2205266A2 (en) * 2007-09-11 2010-07-14 Mondobiotech Laboratories AG Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
EP2595632A1 (en) 2010-07-23 2013-05-29 DemeRx, Inc. Noribogaine compositions
EP2481740B1 (en) 2011-01-26 2015-11-04 DemeRx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
WO2013085922A1 (en) 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
EP2807168A4 (en) 2012-01-25 2015-10-14 Demerx Inc SYNTHETIC VOACANGINE
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
JP2016508979A (ja) 2012-12-20 2016-03-24 デメレックス， インコーポレイテッド 置換ノルイボガイン
US9550789B2 (en) 2014-06-18 2017-01-24 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634331A5 (de) * 1977-06-30 1983-01-31 Hoffmann La Roche Phosphorylierte nonapeptide und verfahren zu deren herstellung.

Also Published As

Publication number Publication date
ZA823369B (en) 1983-03-30
IE821214L (en) 1982-11-21
DE3218761C2 (en, 2012) 1993-05-06
IL65782A0 (en) 1982-08-31
AU8375682A (en) 1982-11-25
EP0065747B1 (de) 1986-10-15
IT8221072A0 (it) 1982-05-04
IE53395B1 (en) 1988-11-09
US4444758A (en) 1984-04-24
PH17981A (en) 1985-02-26
AU552547B2 (en) 1986-06-05
EP0065747A1 (de) 1982-12-01
DE3218761A1 (de) 1982-12-16
US4496545A (en) 1985-01-29
IT1152116B (it) 1986-12-31
CA1188989A (en) 1985-06-18
JPS5823630A (ja) 1983-02-12
IL65782A (en) 1985-08-30

Similar Documents

Publication Publication Date Title
JPH0354089B2 (en, 2012)
Devinsky et al. Safety of intravenous valproate
US4661492A (en) Analgesic compositions
US4935428A (en) Treating opiate dependence
Lang et al. Cardiovascular responses to injections of cholinomimetic drugs into the cerebral ventricles of unanaesthetized dogs
WO2003018015A1 (en) Pharmaceutical composition for preventing drug abuse by pproducing musous membrane irritation
JPS60105617A (ja) 骨炎及び骨髄炎予防治療組成物
Serrano et al. Intramuscular administration of diphenylhydantoin: histologic follow-up studies
JPH0637395B2 (ja) ジペプタイド誘導体を含有する、筋萎縮性側索硬化症を治療するための薬剤
KR20090095668A (ko) 포르시토사이드 주사제와 그 제조 방법
JPS63500799A (ja) 持続性オピオイド拮抗作用を得るための方法および組成物
JP3792251B2 (ja) 手術後の悪心および嘔吐の治療のためのグラニセトロンの使用
JPS5938203B2 (ja) 補酵素ｑを主成分とする脳循環障害治療剤
CA2165446C (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
JP3415643B2 (ja) 筋ジストロフィー症治療薬
CN1244403A (zh) 一种参麦等渗注射液的制备方法
US6114370A (en) Amnesic sedation composition and method of administering same
US20040077636A1 (en) Restricting reinstatement of drug use
HU206261B (en) Process for producing pharmaceutical compositions suitable for treating pulmonary hypertension caused by neutralization by heparin protemin, and comprising 7-oxabicyclo/2.2.1/-5-heptanoic acid derivative as active ingredient
JP3253878B2 (ja) 鉄キレート化用製剤、その製剤の製法及び地中海貧血症の治療法
CH644016A5 (de) Arzneimittel zur behandlung hypertoner funktionszustaende der harnblase.
US20040106671A1 (en) Remedies for vesical hyperesthesia
KR20020031404A (ko) 혈장 대체 조성물
JPS632926A (ja) 安定な、注射可能な制吐性組成物
JP2579187B2 (ja) 中枢鎮痛剤とホルスコリンを活性成分とする組合せ剤